JMP Securities downgraded Deciphera to Market Perform from Outperform after the company entered into an agreement to be acquired by Ono Pharmaceutical for $25.60 per share.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
